GSK

GSK | NYSE

Price Alert Chart Builder DCF Calculator

$50.80

-$0.28 (-0.55%)

Sep 22, 2026, 12:51 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	32.67B	31.38B	30.33B	29.32B	24.7B	24.35B
Cost of Revenue	9.02B	9.05B	8.57B	9.55B	8.16B	7.93B
Gross Profit	23.65B	22.33B	21.76B	19.77B	16.53B	16.43B
Operating Income	8.34B	4.02B	6.75B	6.43B	4.36B	5.98B
Interest Income	56M	67.39M	40M	64.27M	28M	44M
Pretax Income	7.4B	3.48B	6.06B	5.63B	3.6B	5.17B
Net Income	5.72B	2.58B	4.93B	14.96B	4.39B	5.75B
Selling & General & Admin	9.09B	11.02B	9.39B	8.37B	7.07B	7.44B
Research & Development	7.53B	6.4B	6.22B	5.49B	5.02B	4.79B
Other Expenses	-1.3B	891M	-590M	-523M	87M	-1.78B
Operating Expenses	15.31B	18.31B	15.02B	13.34B	12.18B	10.45B
Interest Expense	687M	657.58M	775M	855.53M	784M	892M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	24.33B	27.36B	23.58B	22.89B	20.34B	18.38B
Income Tax Expense	1.11B	526M	756M	707M	83M	67M
Shares Outstanding (Basic)	2.03B	2.04B	2.03B	2.01B	1.6B	1.99B
Shares Outstanding (Diluted)	2.06B	2.07B	2.06B	2.04B	1.62B	2.02B
EPS (Basic)	2.82	1.26	2.44	7.44	2.74	2.88
EPS (Diluted)	2.78	1.24	2.40	7.32	2.70	2.86
EBITDA	10.4B	6.67B	9.08B	8.6B	6.49B	8.07B
EBIT	8.09B	4.12B	6.79B	6.45B	4.36B	6.02B
Depreciation & Amortization	2.31B	2.55B	2.29B	2.15B	2.12B	2.05B